2022--provirex--hamburg-researchers-want-to-be-able-to-cure-hiv-soon---magazine--healty-and-sport-news

Preclinical data showed the enzyme has no measurable cytotoxic or genotoxic side effects, making it a viable candidate for human testing. 3. 2022 Milestones: The Hamburg Therapy Hub

The core of Hamburg’s research is , developed through directed molecular evolution by teams led by Prof. Joachim Hauber. Preclinical data showed the enzyme has no measurable

Research published in Nature Biotechnology demonstrated that Brec1 can target and excise over 90% of clinical HIV-1 isolates found globally. Preclinical data showed the enzyme has no measurable

In October 2022, PROVIREX announced a major expansion in Hamburg’s . Preclinical data showed the enzyme has no measurable